SELLAS Life Sciences Group stock forecast
SELLAS Life Sciences Group (RXK3) Stock Forecast & Price Target
RXK3 Analyst Ratings
RXK3 Stock 12 Month Forecast
Average Price Target
€36.46▲(89.91% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | Maxim Group | €27.35→€36.46 | buy | 89.91%Upside | Assigned | 11/18/26 | ||
| James Molloy | Alliance Global Partners | €9.12→€22.79 | buy | 18.70%Upside | Reiterated | 07/06/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Jason McCarthyMaxim Group | BuyAssigned€27.35→€36.46 | 11/18/26 | 89.91%Upside | ||
| James MolloyAlliance Global Partners | BuyReiterated€9.12→€22.79 | 07/06/26 | 18.70%Upside |
Best Analysts Covering SELLAS Life Sciences Group
Copying Jason McCarthy's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +42.38% per trade.
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +294.15% per trade.
Copying Jason McCarthy's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +499.73% per trade.
RXK3 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 4 | 4 | 3 | 3 |
In the current month, RXK3 has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RXK3 average Analyst price target in the past 3 months is 36.46.
RXK3 Financial Forecast
RXK3 Earnings Forecast
Next quarter’s earnings estimate for RXK3 is -EUR 0.05 with a range of -EUR 0.05 to -EUR 0.05. The previous quarter’s EPS was -EUR 0.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
RXK3 Sales Forecast
Next quarter’s sales forecast for RXK3 is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

